Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of Cardiology.

John W. EikelboomClinical lecturer, University of Western Australia

“Our results suggest that some patients may need more protection than aspirin alone can offer.”

“This very well-known drug may have serious limitations. And those people who are aspirin resistant have a higher risk of dying from heart disease than those who are not.”

“We have patients on aspirin and yet they have a second event. That suggests some resistance or some reason that aspirin is not enough to stop the thrombotic activity.”